BFM
YARW

Boothbay Fund Management’s Yarrow Bioscience YARW Stock Holding History

Boothbay Fund Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,627
Closed -$48.6K – 2672
2026
Q1 		$48.6K Hold
1,627
– – ﹤0.01% 1928
2025
Q4 		$47.2K Sell
1,627
-502
-24% -$10.1K ﹤0.01% 1827
2025
Q3 		$35.7K Hold
2,129
– – ﹤0.01% 1804
2025
Q2 		$176K Buy
+2,129
New +$138K ﹤0.01% 1265
2020
Q3 		– Sell
-13
Closed -$78K – 1238
2020
Q2 		$78K Buy
+13
New +$88K 0.01% 898
2018
Q4 		– Sell
-9
Closed -$315K – 912
2018
Q3 		$315K Buy
+9
New +$278K 0.03% 487

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Boothbay Fund Management's YARW Position: Q2 2026 in Review

Boothbay Fund Management sold out of Yarrow Bioscience (YARW) in Q2 2026, closing a stake of 1,627 shares — an estimated $48.6K sold.

Boothbay Fund Management first reported a position in YARW in Q3 2018 and held it in 6 quarters. The position peaked at $315K in Q3 2018. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Boothbay Fund Management reported no remaining Yarrow Bioscience position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 1,627 Yarrow Bioscience shares in Q2 2026, an estimated $48.6K.
  • Boothbay Fund Management first reported a position in Yarrow Bioscience in Q3 2018 and held it in 6 quarters.
  • Boothbay Fund Management's Yarrow Bioscience position peaked at $315K in Q3 2018.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.